Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Clene Inc.CLNN · Entity 7166 | Director · 10% owner | September 16, 2026 | September 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Clene Inc.
Report date September 16, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common stockSEC Table I · non-derivative | IndirectBy LLC | 478,671 |
Reported balance
After 2026-09-16 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-16 · Grant · Acquired 198,171 · Balance 478,671 F1: Kensington Clene 2021, LLC purchased 198,171 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended. F2: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The securities owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. |
| common stockSEC Table I · non-derivative | Direct | 1,973 |
Reported balance
Holding disclosure · report date 2026-09-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,973 |
| common stockSEC Table I · non-derivative | IndirectBy LP | 150,333 |
Reported balance
Holding disclosure · report date 2026-09-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 150,333 F3: The securities are owned by Kensington Investments, L.P. Ms. Mosca is the chief executive officer of Kensington Investments, L.P. The securities owned by Kensington Investments, L.P. may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by Kensington Investments, L.P., for which she does not have a pecuniary or profits interest. |
| common stockSEC Table I · non-derivative | IndirectBy trust | 72,997 |
Reported balance
Holding disclosure · report date 2026-09-16 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 72,997 F4: The securities are owned by the Robert C. Gay 1998 Family Trust. Ms. Mosca is the trustee of the Robert C. Gay 1998 Family Trust. The securities owned by the Robert C. Gay 1998 Family Trust may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca has no pecuniary interest or profits interest in the securities held by the Robert C. Gay 1998 Family Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Kensington Clene 2021, LLC purchased 198,171 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended.
F2: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The securities owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest.
F3: The securities are owned by Kensington Investments, L.P. Ms. Mosca is the chief executive officer of Kensington Investments, L.P. The securities owned by Kensington Investments, L.P. may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by Kensington Investments, L.P., for which she does not have a pecuniary or profits interest.
F4: The securities are owned by the Robert C. Gay 1998 Family Trust. Ms. Mosca is the trustee of the Robert C. Gay 1998 Family Trust. The securities owned by the Robert C. Gay 1998 Family Trust may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca has no pecuniary interest or profits interest in the securities held by the Robert C. Gay 1998 Family Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2026 Filed Sep 18, 2026 17:40 UTC | Clene Inc. CLNN · Entity 7166 | Grantcommon stock | 198,171 | $3.28 | $650,000.88 |
DisclosureSEC source: 0001437749-26-030728 · rdgdoc.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 478,671 F1 · balance_after: Kensington Clene 2021, LLC purchased 198,171 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The securities owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 19:31 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 4,872 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001437749-26-027970 · rdgdoc.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,872 Underlying: common stock · 4,872 shares Expires 2036-08-12 F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 4,872 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant. Read SEC document |
| May 21, 2026 Filed May 22, 2026 18:02 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 2,861 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001437749-26-018219 · rdgdoc.xml · derivative · entry 2 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,861 Underlying: common stock · 2,861 shares Expires 2036-05-20 F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 2,861 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant. Read SEC document |
| May 21, 2026 Filed May 22, 2026 18:02 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 1,500 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001437749-26-018219 · rdgdoc.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: common stock · 1,500 shares Expires 2036-05-20 F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:04 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 4,201 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001437749-26-004909 · rdgdoc.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,201 Underlying: common stock · 4,201 shares Expires 2036-02-18 F1 · derivative.exercise_date: This option was granted on February 19, 2026 as an option for 4,201 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant. Read SEC document |
| January 13, 2026 Filed Jan 13, 2026 23:46 UTC | Clene Inc. CLNN · Entity 7166 | GrantSeries B Warrants (Right to buy) · Derivative | 46,667 | Not disclosed Strike: $6.00 | Not disclosed |
DisclosureSEC source: 0001104659-26-003464 · tm263117-1_4seq1.xml · derivative · entry 9 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 46,667 Underlying: Common Stock · Not disclosed shares Expires 2029-01-09 F11 · derivative.exercise_price: The exercise price for each Series B Warrant will increase from $6.00 to $12.50 per share if: (i) the Series B Warrant is exercised prior to the Company's public announcement of its receipt of written approval from the FDA of its NDA for CNM-Au8 in ALS or (ii) the VWAP of the Company's common stock is equal to or greater than $25.00 on the associated measurement date. The exercise price of the Series B Warrant will increase to $10.00 per share if the VWAP of the Company's common stock is equal to or greater than $20.00 on the associated measurement date. F12 · shares: The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $15,596,000 by the applicable exercise price. F4 · price: The price of each Unit is $6.50; one Unit consists of one share of Common Stock of Clene Inc., one Series A Warrant and one Series B Warrant. F12 · derivative.underlying_shares: The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $15,596,000 by the applicable exercise price. F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| January 13, 2026 Filed Jan 13, 2026 23:46 UTC | Clene Inc. CLNN · Entity 7166 | GrantSeries A Warrants (Right to buy) · Derivative | 20,000 | Not disclosed Strike: $6.00 | Not disclosed |
DisclosureSEC source: 0001104659-26-003464 · tm263117-1_4seq1.xml · derivative · entry 8 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 20,000 Underlying: Common Stock · Not disclosed shares Expires 2029-01-09 F9 · derivative.exercise_price: The exercise price for each Series A Warrant will increase from $6.00 to $7.00 per share if either: (a) the warrant is exercised prior to the Company's public announcement of the U.S. Food and Drug Administration's (the "FDA") posted action date under the Prescription Drugs User Fee Act for the Company's new drug application ("NDA") for CNM-Au8 (the "Series A Trigger Announcement") or (b) the volume-weighted average price (the "VWAP") of the Company's common stock equals or exceeds $10.00 on the measurement date associated with the Series A Trigger Announcement. F10 · shares: The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $6,684,000 by the applicable exercise price. F4 · price: The price of each Unit is $6.50; one Unit consists of one share of Common Stock of Clene Inc., one Series A Warrant and one Series B Warrant. F10 · derivative.underlying_shares: The reporting person will be entitled to purchase its pro rata share of the number of shares of common stock determined by dividing $6,684,000 by the applicable exercise price. F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| January 13, 2026 Filed Jan 13, 2026 23:46 UTC | Clene Inc. CLNN · Entity 7166 | GrantCommon Stock | 16,667 | $6.00 | $100,002.00 |
DisclosureSEC source: 0001104659-26-003464 · tm263117-1_4seq1.xml · nonDerivative · entry 2 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 280,500 F3 · date: Kensington Clene 2021, LLC entered into a Securities Purchase Agreement with Clene Inc. and the other parties thereto, dated January 8, 2026, for the purchase of 16,667 shares of the Company's common stock, Series A Warrants to purchase 20,000 shares of the Company's common Stock and Series B Warrants to purchase 46,667 shares of the Company's common stock, closing effective January 13, 2026. F4 · price: The price of each Unit is $6.50; one Unit consists of one share of Common Stock of Clene Inc., one Series A Warrant and one Series B Warrant. F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 23:46 UTC | Clene Inc. CLNN · Entity 7166 | OtherTranche A Warrants (Right to buy) · Derivative | 57,219 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001104659-26-003464 · tm263117-1_4seq1.xml · derivative · entry 7 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 62,500 Underlying: Common Stock · 57,219 shares Expires not disclosed F1 · kind: The transaction reported on this line represents a distribution in kind by the limited liability company to a limited partner for no consideration. F8 · derivative.expiration_date: The Tranche A Warrants will expire on the earlier of (a) June 16, 2026, or (b) 60 days after the FDA accepts a New Drug Application from the Company. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 23:46 UTC | Clene Inc. CLNN · Entity 7166 | OtherTranche B Warrants (Right to buy) · Derivative | 57,219 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001104659-26-003464 · tm263117-1_4seq1.xml · derivative · entry 6 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 62,500 Underlying: Common Stock · 57,219 shares Expires not disclosed F1 · kind: The transaction reported on this line represents a distribution in kind by the limited liability company to a limited partner for no consideration. F7 · derivative.expiration_date: The Tranche B Warrants will expire on the earlier of (a) June 16, 2030, or (b) 60 days after the FDA approval of a New Drug Application from the Company. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 23:46 UTC | Clene Inc. CLNN · Entity 7166 | OtherCommon Stock | 57,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-003464 · tm263117-1_4seq1.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 263,833 F1 · kind: The transaction reported on this line represents a distribution in kind by the limited liability company to a limited partner for no consideration. F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:46 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 2,887 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035230 · rdgdoc.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,887 Underlying: common stock · 2,887 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 2,887 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 13:09 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 5,674 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027072 · rdgdoc.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,674 Underlying: common stock · 5,674 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 5,674 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| May 22, 2025 Filed May 23, 2025 18:16 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 7,984 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001562180-25-004123 · primarydocument.xml · derivative · entry 2 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,984 Underlying: Common Stock · 7,984 shares Expires 2035-05-21 F2 · derivative.exercise_date: This option was granted on May 22, 2025 as an option for 7,984 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $2.45 per share. The options vest immediately upon grant. Read SEC document |
| May 22, 2025 Filed May 23, 2025 18:16 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 1,500 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001562180-25-004123 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2035-05-21 F1 · derivative.exercise_date: This option was granted on May 22, 2025 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $2.45 per share. The options vest in 12 equal monthly installments on the 22nd day of each calendar month, beginning June 22, 2025, until such shares are fully vested. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:24 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 4,402 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001562180-25-001812 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,402 Underlying: Common Stock · 4,402 shares Expires 2035-02-26 F1 · derivative.exercise_date: This option was granted on February 27, 2025 as an option for 4,402 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.42 per share. The options vest immediately upon grant. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 21:16 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 4,350 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001562180-24-008237 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,350 Underlying: Common Stock · 4,350 shares Expires 2034-12-05 F1 · derivative.exercise_date: This option was granted on December 6, 2024 as an option for 4,350 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.40 per share. The options vest immediately upon grant. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:12 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 3,902 | $0.00 Strike: $4.89 | $0.00 |
DisclosureSEC source: 0001562180-24-007212 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,902 Underlying: Common Stock · 3,902 shares Expires 2034-10-01 F1 · derivative.exercise_date: This option was granted on October 2, 2024 as an option for 3,902 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.89 per share. The options vest immediately upon grant. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:12 UTC | Clene Inc. CLNN · Entity 7166 | GrantCommon Stock Purchase Warrant (Right to buy) · Derivative | 159,134 | $0.13 Strike: $4.82 | $19,891.75 |
DisclosureSEC source: 0001104659-24-105443 · tm2425372-1_4seq1.xml · derivative · entry 5 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 159,134 Underlying: Common Stock · 159,134 shares Expires 2029-10-01 F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:12 UTC | Clene Inc. CLNN · Entity 7166 | GrantCommon Stock | 159,134 | $4.59 | $730,106.79 |
DisclosureSEC source: 0001104659-24-105443 · tm2425372-1_4seq1.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 321,052 F1 · balance_after: On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's ownership in the previously disclosed 3,238,375 shares of common stock indirectly owned being reduced to 161,918 shares. F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 20:14 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 51,399 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001562180-24-004889 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,399 Underlying: Common Stock · 51,399 shares Expires 2034-06-06 F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 51,399 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant. Read SEC document |
| May 29, 2024 Filed May 31, 2024 18:33 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001562180-24-004536 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 20:19 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 44,959 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001562180-24-002592 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,959 Underlying: Common Stock · 44,959 shares Expires 2034-03-11 F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 44,959 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant. Read SEC document |
| November 28, 2023 Filed Nov 29, 2023 21:08 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 43,814 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-23-007966 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,814 Underlying: Common Stock · 43,814 shares Expires 2033-11-28 F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 43,814 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant. Read SEC document |
| September 18, 2023 Filed Sep 19, 2023 20:08 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 36,490 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001562180-23-006936 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,490 Underlying: Common Stock · 36,490 shares Expires 2033-09-18 F1 · derivative.exercise_date: This option was granted on September 18, 2023 as an option for 36,490 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.54 per share. The options vest immediately upon grant. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 15:02 UTC | Clene Inc. CLNN · Entity 7166 | GrantWarrants (Right to buy) · Derivative | 2,394,375 | Not disclosed Strike: $1.10 | Not disclosed |
DisclosureSEC source: 0001562180-23-005323 · primarydocument.xml · derivative · entry 6 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,394,375 Underlying: Common Stock · 2,394,375 shares Expires not disclosed F4 · price: The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant. F6 · derivative.expiration_date: Kensington Clene 2021, LLC purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche A Warrant is for 2,394,375 shares of Common Stock of Clene Inc. at an exercise price of $1.10 per share. The Tranche A Warrant will expire on the earlier of (a) June 16, 2026, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 15:02 UTC | Clene Inc. CLNN · Entity 7166 | GrantWarrants (Right to buy) · Derivative | 2,394,375 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001562180-23-005323 · primarydocument.xml · derivative · entry 5 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,394,375 Underlying: Common Stock · 2,394,375 shares Expires not disclosed F4 · price: The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant. F5 · derivative.expiration_date: Kensington Clene 2021, LLC purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche B Warrant is for 2,394,375 shares of Common Stock of Clene Inc. at an exercise price of $1.50 per share. The Tranche B Warrant will expire on the earlier of (a) June 16, 2030, or (b) 60 days after the Food and Drug Administration approval of a New Drug Application from Clene Inc. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 15:02 UTC | Clene Inc. CLNN · Entity 7166 | PurchaseCommon Stock | 2,394,375 | $0.80 | $1,915,500.00 |
DisclosureSEC source: 0001562180-23-005323 · primarydocument.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 3,238,375 F1 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Please note that Kensington Clene 2021, LLC had been incorrectly referred to in prior form 4s for Ms. Mosca as Kensington Clene, LLC; there is no such legal entity, only Kensington Clene 2021, LLC. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:36 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $0.92 | $0.00 |
DisclosureSEC source: 0001562180-23-003964 · primarydocument.xml · derivative · entry 2 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-04 F2 · derivative.exercise_date: This option was granted on May 4, 2023 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $0.92 per share. The options vest in 12 equal installments of Common Stock on the 4th day of each calendar month, beginning June 4, 2023, until such shares are fully vested. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:36 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 21,607 | $0.00 Strike: $0.92 | $0.00 |
DisclosureSEC source: 0001562180-23-003964 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,607 Underlying: Common Stock · 21,607 shares Expires 2033-05-04 F1 · derivative.exercise_date: This option was granted on May 4, 2023 as an option for 21,607 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $0.92 per share. The options vest immediately upon grant. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:00 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 12,430 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001562180-23-000895 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,430 Underlying: Common Stock · 12,430 shares Expires 2033-02-02 F1 · derivative.exercise_date: This option was granted on February 2, 2023 as an option for 12,430 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.62 per share. The options vest immediately upon grant. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 19:50 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 16,795 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001562180-22-007508 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,795 Underlying: Common Stock · 16,795 shares Expires 2032-11-03 F1 · derivative.exercise_date: This option was granted on November 3, 2022 as an option for 16,795 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.19 per share. The options vest immediately upon grant. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 11:57 UTC | Clene Inc. CLNN · Entity 7166 | PurchaseCommon Stock | 792,079 | $1.01 | $799,999.79 |
DisclosureSEC source: 0001562180-22-007455 · primarydocument.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 844,000 F1 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The shares owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest. Please note that Kensington Clene 2021, LLC had been incorrected referred to in prior form 4s for Ms. Mosca as Kensington Clene, LLC; there is no such legal entity, only Kensington Clene 2021, LLC. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 18:06 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 5,253 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001562180-22-005902 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,253 Underlying: Common Stock · 5,253 shares Expires 2032-08-04 F1 · derivative.exercise_date: This option was granted on August 4, 2022 as an option for 5,253 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.79 per share. The options vest immediately upon grant. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 11:14 UTC | Clene Inc. CLNN · Entity 7166 | PurchaseCommon Stock | 5,000 | $2.62 | $13,100.00 |
DisclosureSEC source: 0001562180-22-005129 · primarydocument.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,476 F1 · price: Ms. Mosca purchased 5,000 shares of common stock of Clene Inc. on June 15, 2022 at a price of $2.62 per share. Read SEC document |
| May 05, 2022 Filed May 6, 2022 15:55 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 6,976 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001562180-22-003856 · primarydocument.xml · derivative · entry 2 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,976 Underlying: Common Stock · 6,976 shares Expires 2032-05-05 F2 · derivative.exercise_date: This option was granted on May 5, 2022 as an option for 6,976 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.89 per share. The options vest immediately upon grant. Read SEC document |
| May 05, 2022 Filed May 6, 2022 15:55 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001562180-22-003856 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-05-05 F1 · derivative.exercise_date: This option was granted on May 5, 2022 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.89 per share. The options vest in 12 equal installments of Common Stock on the 5th day of each calendar month, beginning June 5, 2022, until such shares are fully vested. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:36 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 7,587 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001121 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,587 Underlying: Common Stock · 7,587 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 7,587 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 21:50 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 4,419 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006877 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,419 Underlying: Common Stock · 4,419 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 4,419 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| October 01, 2021 Filed Jan 20, 2022 21:39 UTC | Clene Inc. CLNN · Entity 7166 | OtherWarrants (Right to buy) · Derivative | 10,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001596771-22-000001 · primary_doc.xml · derivative · entry 4 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-12-30 F2 · ownership.nature: The securities are owned by the Robert C. Gay 1998 Family Trust. Ms. Mosca is the trustee of the Robert C. Gay 1998 Family Trust. The securities owned by the Robert C. Gay 1998 Family Trust may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca has no pecuniary or profits interest in the securities held by the Robert C. Gay 1998 Family Trust. Read SEC document |
| October 01, 2021 Filed Jan 20, 2022 21:39 UTC | Clene Inc. CLNN · Entity 7166 | OtherWarrants (Right to buy) · Derivative | 15,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001596771-22-000001 · primary_doc.xml · derivative · entry 3 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LP Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2021-12-30 F1 · ownership.nature: The securities are owned by Kensington Investments, L.P. ("KI"). Ms. Mosca is the president of Kensington Management LLC, which is the general partner of KI, and also serves as the trustee of the Robert C. Gay Revocable Trust, which is the limited partner of KI. The securities owned by KI may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by KI, for which she does not have a pecuniary or profits interest. Read SEC document |
| October 01, 2021 Filed Jan 20, 2022 21:39 UTC | Clene Inc. CLNN · Entity 7166 | OtherCommon Stock | 10,000 | $0.01 | $100.00 |
DisclosureSEC source: 0001596771-22-000001 · primary_doc.xml · nonDerivative · entry 2 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,459,945 F2 · ownership.nature: The securities are owned by the Robert C. Gay 1998 Family Trust. Ms. Mosca is the trustee of the Robert C. Gay 1998 Family Trust. The securities owned by the Robert C. Gay 1998 Family Trust may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca has no pecuniary or profits interest in the securities held by the Robert C. Gay 1998 Family Trust. Read SEC document |
| October 01, 2021 Filed Jan 20, 2022 21:39 UTC | Clene Inc. CLNN · Entity 7166 | OtherCommon Stock | 15,000 | $0.01 | $150.00 |
DisclosureSEC source: 0001596771-22-000001 · primary_doc.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LP Disclosed balance after: 3,006,670 F1 · ownership.nature: The securities are owned by Kensington Investments, L.P. ("KI"). Ms. Mosca is the president of Kensington Management LLC, which is the general partner of KI, and also serves as the trustee of the Robert C. Gay Revocable Trust, which is the limited partner of KI. The securities owned by KI may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by KI, for which she does not have a pecuniary or profits interest. Read SEC document |
| August 05, 2021 Filed Aug 5, 2021 22:23 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 2,267 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0001562180-21-005199 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,267 Underlying: Common Stock · 2,267 shares Expires 2031-08-05 F1 · derivative.exercise_date: This option was granted on August 5, 2021 as an option for 2,267 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant. Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 23:12 UTC | Clene Inc. CLNN · Entity 7166 | GrantCommon Stock | 2,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004956 · primarydocument.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,083 F1 · shares: This stock award was granted on July 14, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on the date of grant. Read SEC document |
| May 24, 2021 Filed May 24, 2021 22:59 UTC | Clene Inc. CLNN · Entity 7166 | PurchaseCommon Stock | 51,921 | $9.63 | $499,999.23 |
DisclosureSEC source: 0001562180-21-003709 · primarydocument.xml · nonDerivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by LLC Disclosed balance after: 51,921 F1 · ownership.direct: Kensington Clene, LLC purchased 51,291 shares of common stock of Clene Inc on May 24, 2021 for a purchase price of $9.63 per share. Ms. Mosca is the sole manager of Kensington Clene, LLC F2 · ownership.nature: The securities are owned by the Kensington Clene, LLC. Ms. Mosca is the sole manager of and owned a minority interest in Kensington Clene, LLC. The shares owned by the Kensington Clene, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene, LLC, for which she does not have a pecuniary or profits interest. Read SEC document |
| May 18, 2021 Filed May 18, 2021 23:27 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 2,626 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001562180-21-003575 · primarydocument.xml · derivative · entry 2 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,626 Underlying: Common Stock · 2,626 shares Expires 2031-05-18 F2 · shares: This option was granted on May18, 2021 as an option for 2,626 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant. F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 2,626 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant. Read SEC document |
| May 18, 2021 Filed May 18, 2021 23:27 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001562180-21-003575 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-05-18 F1 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested Read SEC document |
| May 18, 2021 Filed May 25, 2021 18:54 UTC Amendment | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $9.10 | $0.00 |
DisclosureSEC source: 0001562180-21-003722 · primarydocument.xml · derivative · entry 2 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-05-18 F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc. F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested. Read SEC document |
| May 18, 2021 Filed May 25, 2021 18:54 UTC Amendment | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 2,479 | $0.00 Strike: $9.10 | $0.00 |
DisclosureSEC source: 0001562180-21-003722 · primarydocument.xml · derivative · entry 1 Mosca Alison · CIK 0001835537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,479 Underlying: Common Stock · 2,479 shares Expires 2031-05-18 F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 2,479. F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 2,479 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.